PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $42,000 | -76.0% | 8,412 | -54.8% | 0.00% | -77.8% |
| Q1 2017 | $175,000 | +548.1% | 18,610 | +281.0% | 0.02% | +260.0% |
| Q3 2015 | $27,000 | +42.1% | 4,885 | +87.7% | 0.01% | +66.7% |
| Q2 2015 | $19,000 | +18.8% | 2,602 | +18.2% | 0.00% | -40.0% |
| Q4 2014 | $16,000 | – | 2,202 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |